December 6, 2016

Lexington Medical opens new headquarters in Billerica

Lexington Medical is developing abdominal surgical instruments, with a novel business model designed to substantially lower costs of healthcare delivery. The company was founded by medical device industry veterans with experience in both S&P 500 medical device suppliers as well as innovative technology start-ups. The new 8,000 square feet facility will house Lexington Medical’s 10 employees, with room for future growth.

Read the Press Release Here

lexington-medical-ribbon-cutting-12-6-16

Nancy Cadigan, Aide to State Representative Marc Lombardo (R-Billerica), Leon Amariglio, Founder and CEO of Lexington Medical, Travis McCready, President & CEO of the Massachusetts Life Sciences Center, and Kendalle Burlin O’Connell, VP for Member Services & General Counsel at MassBio, celebrate the grand opening of Lexington Medical’s new headquarters in Billerica, Massachusetts

October 27, 2016

Holst Center Launches in North America

Holst Centre, a leading Dutch research institute in the area of flexible electronics and wireless sensing, based in Eindhoven the Netherlands, hosted an introductory event at the Cambridge Innovation Center to announce their expansion into Massachusetts and bolster relationships in North America. The event was supported by the Province of Noord-Brabant, the Netherlands.

Read the press release here »

October 3, 2016

Grand opening ceremony of LEO Science & Tech Hub in Cambridge

Her Royal Highness Crown Princess Mary of Denmark and Danish Minister for Business and Growth Troels Lund Poulsen officially inaugurated the LEO Science & Tech Hub. The Hub aims to catalyze early-stage collaborations in science and technology in order to advance the treatment of skin diseases and is the first of its kind to focus on dermatology in Massachusetts, the world’s leading life science ecosystem.

leo-pharma

Photo Caption: From left to right: Her Royal Highness, Crown Princess Mary of Denmark and LEO Pharma President & CEO Gitte Pugholm Aabo celebrate the opening of the LEO Science & Tech Hub at the Cambridge Innovation Center

Read the press release here »

September 28, 2016

ABI-LAB Celebrates its Grand Opening in Natick Massachusetts

ABI-LAB, an accelerator and bioincubator shared laboratory facility that supports startup companies through availability of affordable lab space and innovative pre-clinical services had a grand opening ceremony in Natick, Massachusetts.

Read the Press Release here.

abilab-ribbon-cutting-ceremony

Photo Caption: From left to right, (third from left) MassBio Manager, Member Recruitment Laura Hamilton, State Senator Richard Ross State, Senator Karen Spilka, Gary Kaufman, Managing Partner of ABI-LAB, Dr. Rafael Nir, Managing Partner of ABI-LAB, and MLSC Vice President for Communications & Marketing Angus McQuilken (last from right).

 

September 23, 2016

Massachusetts Life Sciences Center Announces New Appointees to Board of Directors

The Massachusetts Life Sciences Center (MLSC) announced today that Governor Charlie Baker has appointed Pam Randhawa, Founder and Chief Executive Officer of Empiriko Corporation and Gary Paul Kearney, M.D., past President of the Medical Staff, Chief of Urology, and Vice Chairman of the Department of Surgery at New England Baptist Hospital, to the MLSC Board of Directors.

Read the Press Release here.

September 14, 2016

FDA clears icometrix’ image quantification software to monitor neurological disorders

After opening a subsidiary in the Boston area earlier this year, Belgian health tech company icometrix has obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for their image quantification software, icobrain. icobrain quantifies key features of clinical MRI brain scans, which enable clinicians to monitor how their patient’s brain changes over time.

Read the press release here »

July 15, 2016

The Massachusetts Life Sciences Center and Massachusetts General Hospital launch the Massachusetts Center for Alzheimer Therapeutics Science (MassCATS)

The Massachusetts Life Sciences Center (MLSC), Massachusetts General Hospital (MGH) and five leading biopharma companies have launched the Massachusetts Center for Alzheimer Therapeutics Science (MassCATS), a unique collaboration among world-class industry and academic researchers working to find therapies for Alzheimer’s disease.  The new Center will be located at MGH.  Industry partners, including AbbVie, Biogen, Janssen Pharmaceuticals, Inc., Merck and Sunovion Pharmaceuticals have committed $1.25 million in Alzheimer’s-related research funding.

Read the press release here

MassCATS photo 1

(left to right).  Massachusetts Assistant Secretary for Economic Development Mike Kennealy, Alzheimer’s advocate and caregiver Brenda Bouchard, Massachusetts Secretary for Housing & Economic Development Jay Ash, Director of MA Alzheimer’s Disease Research Center Brad Hyman, Ph.D., Massachusetts General Hospital President & CEO Peter Slavin, Massachusetts Life Sciences Center General Counsel and VP for Academic & Workforce Programs Beth Nicklas, and Massachusetts Life Sciences Center President & CEO Travis McCready celebrate the launch of the new Massachusetts Center for Alzheimer Therapeutics Science (MassCATS) at Massachusetts General Hospital.
June 29, 2016

Eurofins Lancaster Laboratories expands Northeast footprint; opens first office in Cambridge, Mass.

Eurofins Lancaster Laboratories, a global leader in bio/pharmaceutical laboratory services, announced today the opening of its Northeast office, located in the Cambridge Innovation Center (CIC) in Cambridge, Massachusetts.

Backed by a 55-year successful track record, Eurofins Lancaster Laboratories offers a complete range of CMC Testing Services to support virtual and large bio/pharmaceutical companies and CMOs worldwide, including testing of all starting materials, process intermediates, bulk drug, finished product, and final packaging components through its broad technical expertise in Biochemistry, Molecular & Cell Biology, Virology, Chemistry and Microbiology.

Read the Press Release here

June 13, 2016

French-based ‘Live Biotherapeutic’ Company Biose to open their first US office in Cambridge

BIOSE®, a French pharmaceutical company, the Massachusetts Life Sciences Center, and MassBio announced that BIOSE® is opening their first US office in Cambridge, Massachusetts at the Cambridge Innovation Center.  BIOSE®’s mission is to design and market the best live biotherapeutic products to improve human health. Their Massachusetts office will primarily focus on licensing activities.

Read the Press Release here

IMG_20160607_134203

Maxence Desjonquères (far left), CEO of Biose, meets with Massachusetts life sciences and economic development leaders in the Massachusetts Pavilion at the BIO 2016 Convention in San Francisco, including (from left to right) Travis McCready, President & CEO of the Massachusetts Life Sciences Center, Lisa Hemmerle, Director of Economic Development for the City of Cambridge, Pamela Norton, Vice President for Industry Relations & Programs at the Massachusetts Life Sciences Center, and Jay Ash, Massachusetts Secretary for Housing & Economic Development.
June 8, 2016

Massachusetts Life Sciences Center announces Grant Program focused on attracting new companies

Massachusetts Transition and Growth Program (“MassTAG”) will provide grant funding to companies to help them establish operations in Massachusetts.

Read the Press Release Here

photo MassTAG

Photo Caption:

Massachusetts life sciences leaders announce the launch of the MLSC’s new MassTAG program at the 2016 BIO International Convention.  From left to right, Massachusetts Housing & Economic Development Secretary Jay Ash (at podium), MLSC President & CEO Travis McCready, MassBio President & CEO Bob Coughlin, Nanobiotix USA CEO Patrick Tricoli, City of Boston Chief of Economic Development John Barros, and Cambridge Economic Development Director Lisa Hemmerle.

May 26, 2016

Massachusetts Life Sciences Center announces $1.5 million in Accelerator loans for promising early-stage companies

The Massachusetts Life Sciences Center (MLSC) announced today the awarding of $1.5 million in Accelerator loan financing to two promising early-stage companies, Lexington-based MX Orthopedics Corp, and Bedford-based First Light Biosciences Inc.

Read the Press Release Here

MX Orthopedics Corp., Lexington – $750,000

  • MX Orthopedics Corp. is a medical device company focused on the development and commercialization of innovative and effective orthopedic devices such as compression staples, screws, plates and intramedullary implants, made from the shape memory alloy Nitinol.
  • Their dynaMX line of fraction fixation implants is designed to address a problem with existing fracture fixation devices; using Nitinol’s properties, these devices will be able to generate and maintain greater compression across the fracture site.
  • Funding from the MLSC will help MX Orthopedics move towards commercialization. MLSC funds will accelerate the filling of key positions to scale up the launch efforts. Funds will also enable the purchasing of inventory for their potential OEM distribution partner.

First Light Biosciences Inc., Bedford – $750,000

  • First Light is commercializing products for rapidly detecting and treating deadly hospital infections.
  • The company’s technology focuses on delivering affordable rapid tests to detect multiple types of hospital infections, including C-difficile, MERSA and urinary tract infections and identify the infectious agent causing them.
  • Their technology enables not only the identification of the pathogen, but also the identification of the optimal antibiotic to treat the patient. They intend to deliver this product at a cost similar to culturing.
  • First Light’s MultiPath platform is an automated bench top analyzer that expects to be able to accommodate a menu of application-specific cartridges.
  • A loan from the MLSC will help First Light Biosciences accelerate the commercialization of their initial consumable diagnostic testing product, and hire and support 3 assay development scientists to accomplish that objective and push forward to achieve FDA approval.
May 20, 2016

Massachusetts Life Sciences Center to Launch Capital Project Solicitations May 27 & May 31

The Massachusetts Life Sciences Center (MLSC) announced today that the agency will launch an open solicitation for life-sciences-related capital projects on May 27th, and an open solicitation for high school and middle school equipment & supply grants on May 31st. Funding for both programs was included in the Baker/Polito Administration’s capital plan that was released yesterday.  The Administration’s Fiscal Year 2017 capital plan provides $63.6 million for the Massachusetts Life Sciences Center, a 15% increase over the Center’s projected spending of $55 million in FY16.

Read the Press Release Here

May 19, 2016

Life Sciences High School Apprenticeship Training Program Graduates First Class of Students

The Massachusetts Life Sciences Center and the BioBuilder Educational Foundation held their first-ever graduation ceremony for Life Sciences High School Apprentices at LabCentral in Cambridge. Twenty-seven students from Boston and Cambridge have successfully completed an eight-week lab-readiness training program as part of the newly established Life Sciences High School Apprenticeship Challenge training program, the pilot year of which was funded by a $50,000 grant from the Massachusetts Life Sciences Center (MLSC).

Read the Press Release Here»

Apprenticeship graduation photo

Massachusetts Life Sciences Center President & CEO Travis McCready congratulates one of the graduates of the Life Sciences High School Apprenticeship Challenge training program
April 28, 2016

Web Industries Opens New Lateral Flow Immunoassay (LFI) Manufacturing Facility

Web Industries, Inc., innovative provider of precision contract manufacturing and converting services, is proud to announce the opening of the company’s first lateral flow immunoassay (LFI) production facility. Co-located within the company’s existing Web Boston location, the Lateral Flow Diagnostics Center of Excellence will provide companies marketing LFI tests with a one-stop outsource manufacturing solution that offers a reliable path from small-scale test development to high-volume commercialization of new LFI devices. The 6,500 square foot environmentally-controlled facility was purpose-built for automated reel-to-reel medical device production and features an in-house biochemistry lab, reagent deposition, LFI strip manufacturing, device assembly, and packaging stations.

Read the press release here »

IMG_0481
From left to right Dennis Latimer, Executive Vice President of Strategy and M&A, Blake Batley, Chief Sales & Marketing Officer, Mark Pihl, President & Chief Operating Officer, Don Romine, Chief Executive Officer, and Jon Nuñez, Chief Financial Officer cut a ribbon to celebrate the Lateral Flow Diagnostics Center of Excellence in Holliston, MA.
April 27, 2016

Baker-Polito Administration Awards Job Creation Incentives to 28 Life Science Companies

The Baker-Polito Administration announced $20 million in tax incentive awards, to 28 life sciences companies. The awards, which will create 1,325 new jobs in the Commonwealth in 2016, were approved today by the Board of Directors of the Massachusetts Life Sciences Center (MLSC). The tax incentive awards will support life sciences job growth in fourteen Massachusetts cities and towns; half of the awardees are located or are expanding outside of Greater Boston.

Read the press release here »

Company Location Incentive Amount Jobs
908 Devices Inc. Boston $165,000 11
AbbVie Inc. Worcester $525,000 35
Abiomed, Inc. Danvers $1,050,000 70
Alnylam Pharmaceuticals, Inc. Cambridge $2,250,000 150
Amgen Inc. Cambridge $780,000 52
Baxalta US, Inc. Cambridge $1,320,000 66
Charles River Laboratories, Inc. Wilmington $1,200,000 80
Emulate, Inc. Boston $318,090 30
Enanta Pharmaceuticals, Inc. Watertown $360,000 24
Ginkgo Bioworks, Inc. Boston $483,377 50
Juno Therapeutics, Inc. Waltham $165,000 11
LFB USA, Inc. Framingham $720,000 48
Masy Systems, Inc. Pepperell $150,000 10
Merrimack Pharmaceuticals, Inc. Cambridge $225,000 15
Moderna Therapeutics, Inc. Cambridge $1,875,000 125
Nitto Denko Avecia Inc. Milford $450,000 30
Nova Biomedical Corporation Waltham $750,000 50
Pharmalucence, Inc. Billerica $150,000 10
Quanterix Corporation Lexington $225,000 15
Radius Health, Inc. Waltham $525,000 35
Sarepta Therapeutics, Inc. Cambridge $750,000 50
Seres Therapeutics, Inc. Cambridge $945,000 63
Shire Human Genetic Therapies, Inc. Lexington $2,250,000 150
Siemens Healthcare Diagnostics, Inc. Walpole $735,000 30
SQZ Biotechnologies Company Boston $129,784 20
STC Biologics, Inc. Cambridge $150,000 10
Takeda Pharmaceuticals America, Inc. Cambridge $1,125,000 75
Web Industries Boston, Inc. Holliston $150,000 10

 

Connect With Us

Facebook LinkedIn Twitter